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ABSTRACT
Dicer, an endoribonuclease best-known for its role in microRNA biogenesis and 
RNA interference pathway, has been shown to play a role in the DNA damage response 
and repair of double-stranded DNA breaks (DSBs) in mammalian cells. However, it 
remains unknown whether Dicer is also important to preserve genome integrity upon 
replication stress. To address this question, we focused our study on common fragile 
sites (CFSs), which are susceptible to breakage after replication stress. We show that 
inhibition of the Dicer pathway leads to an increase in CFS expression upon induction 
of replication stress and to an accumulation of 53BP1 nuclear bodies, indicating 
transmission of replication-associated damage. We also show that in absence of a 
functional Dicer or Drosha, the assembly into nuclear foci of the Fanconi anemia (FA) 
protein FANCD2 and of the replication and checkpoint factor TopBP1 in response to 
replication stress is impaired, and the activation of the S-phase checkpoint is defective. 
Based on these results, we propose that Dicer pre-vents genomic instability after 
replication stress, by allowing the proper recruitment to stalled forks of proteins 
that are necessary to maintain replication fork stability and activate the S-phase 
checkpoint, thus limiting cells from proceeding into mitosis with under-replicated DNA. 
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INTRODUCTION
DNA replication is a fundamental cellular process 
that needs to be tightly regulated to maintain the genetic 
information through generations. Any challenge to this 
process slowing down or stalling the replication fork 
constitutes a Replication Stress (RS) that can have severe 
implications for genome stability, cell survival and even 
human diseases. Indeed, RS is considered a major driver 
of tumor initiation and progression. Some genomic 
regions, like Common fragile sites (CFSs), are particularly 
sensitive to RS and tend to form gaps or breaks on mitotic 
chromosomes after replication stress. CFSs are present in 
all individuals, lie in late-replicating regions and represent 
a significant source of genetic instability in cancer cells 
[1, 2]. The late replication and origin paucity of CFSs 
increase the risk of remaining incompletely replicated 
at the time of mitosis upon replication stress, when cells 
are unable of rescuing replication fork stalling/slowing 
and transcription-replication conflicts [1, 3–6]. When 
replication is challenged, the S-phase checkpoint is 
activated to protect stalled replication forks from collapsing 
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and to delay cell cycle progression, preventing cells from 
entry into mitosis in presence of under-replicated or 
damaged DNA [7–10]. The activation of this checkpoint 
requires the relocalization into nuclear foci and the stepwise 
activation of proteins of the ATR-Chk1 and the Fanconi 
Anemia (FA) pathways [11], including Topoisomerase 
II Binding Protein 1 (TopBP1) and FANCD2 [12–15]. 
TopBP1 recruitment to sites of stalled replication forks 
or DNA damage is a crucial step for activating the ATR 
kinase and for its subsequent Chk1 phosphorylation [16]. 
FANCD2 is the key activated target of the FA pathway, 
deficient in Fanconi Anemia chromosomal instability 
and cancer-prone disorder, and is involved in replication 
stress response and inter-strand crosslink (ICL) repair [17]. 
Following replication stress or DNA damage, FANCD2 
is mono-ubiquitylated by the FA core complex which 
promotes replication fork recovery and ICL repair, together 
with downstream components of the FA pathway, such as 
structure-specific endonucleases, translesion synthesis 
polymerases and homologous recombination proteins. 
Non-coding RNAs (ncRNAs) have diverse roles 
in regulating transcriptional and post-transcriptional 
processes, chromatin dynamics, and cellular homeostasis 
[18, 19]. Micro RNAs (miRNAs) constitute a large class of 
small ncRNAs with a prominent role in regulation of gene 
expression [20]. They have also an essential role in cell 
viability and proliferation, but details of their mechanism 
of action remain largely unknown [21, 22]. The biogenesis 
of miRNAs is mediated by two main RNases: Drosha, 
which processes long primary precursor transcripts 
(pri-miRNAs) in the nucleus, and Dicer, which cleaves 
the secondary miRNA precursors (pre-miRNAs) in the 
cytoplasm to produce mature 21–25 nucleotide miRNAs 
[23, 24]. Intriguingly, it has been reported that some 
fragile sites and common breaking regions of both the 
human and murine genomes are located close to miRNA 
genes [25, 26]. In addition, cancer often correlates with 
alterations at ultra-conserved genomic areas expressing 
ncRNAs [27], suggesting that these RNAs might be 
involved in maintaining the stability of these sites under 
stress conditions. Other recent studies have shown that 
Dicer-processed RNA products are involved in DNA 
double-strand break (DSB) repair. These DDRNAs (DNA 
Damage response RNAs) are produced in the vicinity 
of the DSB sites and are used to facilitate the repair by 
mediating the binding of chromatin modifiers at the sites 
of damage [28–32]. RNA processing by both Dicer and 
Drosha following break induction in human cells promotes 
repair by both homologous recombination and non-
homologous end joining [29, 32, 33]. In addition, Dicer 
itself, independently of its ribonuclease activity, has been 
recently discovered to be involved in Nucleotide Excision 
Repair (NER) by mediating the chromatin decompaction 
necessary to remove DNA lesions induced by UV light 
exposure [34–36]. 
Albeit the involvement of Dicer in DNA repair 
is quite clear and some progresses have been done 
to disclose the underlying mechanism, these aspects 
still remain elusive. Conventionally considered as a 
cytoplasmic protein, Dicer can relocalize to the nucleus 
thanks to its non-canonical Nuclear Localisation Signal 
(NLS) [37]. In fact, it has been demonstrated that in both 
humans and mice after DNA damage a fraction of Dicer 
is phosphorylated and accumulated in the nucleus to 
promote the recruitment of DNA repair factors [38, 39]. 
Strikingly, it has been shown that in yeast, Dicer promotes 
the release of RNA polymerase II from the termination site 
of highly transcribed genes and process the RNA:DNA 
hybrids resulting from transcription-replication collisions 
to maintain genome stability [40]. More recently, it has 
been demonstrated that Drosha-driven RNA:DNA hybrids 
localize around DSB sites, at the very beginning after 
H2A.X phosphorylation and ATM activation but before 
the accumulation of 53BP1 and DDRNAs - of the DNA 
damage response, suggesting that these structures have a 
key role in the DNA damage repair [41].
However, whether the Dicer pathway plays 
a role in the response to replication stress in higher 
eukaryotes is still not known. To investigate this, we used 
HCT116 cells, either Dicer-deficient or knocked down 
for Dicer and Drosha, to study the effect of the Dicer 
pathway impairment on CFS stability after induction of 
replication stress. Our data show that Dicer is required for 
maintaining genomic stability after replication stress and 
acts by promoting the recruitment of proteins involved 
in replication fork stability and S-phase checkpoint 
activation. Therefore, Dicer prevents cells from entering 
a mitosis with under-replicated DNA that would 
otherwise result in chromosome breaks and DNA damage 
transmission to daughter cells.
RESULTS 
Inhibition of Dicer enhances genomic instability 
and fragility at CFSs
To ascertain possible roles of the Dicer pathway in the 
DNA damage response induced by replication stalling, we 
investigated its function in genomic stability after treatment 
with mild doses of aphidicolin, an inhibitor of DNA 
polymerases, commonly used to induce breaks preferentially 
at CFSs [42]. To this end, we knocked down Dicer or Drosha 
in HCT116 cells, used as a model to study CFSs [43]. Cells 
were transfected with siRNA (small interfering RNA) pools 
targeting either Dicer or Drosha, and LacZ as a control. 
Dicer and Drosha protein levels were assayed by western 
blotting (Figure 1A). siRNAs targeting Dicer (siDicer) led 
to a significant decrease of Dicer expression and a partial 
decrease of Drosha expression; instead, siRNAs targeting 
Drosha (siDrosha) specifically reduced just the protein levels 
of Drosha. Both siRNA pools did not affect levels of Piwi, 
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a protein that binds to another class of small non-coding 
RNAs called piRNAs, indicating the specificity of the RNAi 
[44]. Then, Dicer and Drosha-depleted cells were treated 
with aphidicolin to induce replication stress and metaphase 
spreads were analyzed. Inhibition of both Dicer and Drosha 
resulted in a significant increase in the average number of 
chromosomal breaks after aphidicolin treatment compared 
to the control (Figure 1B–1C). 
To study further the role of Dicer in maintaining 
genome stability upon replication stress, we used an 
HCT116 cell line that is mutated in the RNA helicase 
domain of Dicer. These cells, hereafter named Dicer Ex5/
Ex5, have an in-frame 129-bp homozygous insertion 
in Exon 5 of the Dicer gene, which inactivates its RNA 
helicase domain [45, 46]. This mutation was verified 
by PCR (Supplementary Figure 1A) and was shown 
to lead to a significant reduction in the levels of Dicer 
(Supplementary Figure 1B). These cells and their isogenic 
WT (Wild Type) Dicer counterparts were treated with 
aphidicolin and metaphase spreads were obtained as 
described above. Consistent with the results following 
Dicer knock down, the frequency of chromosome breaks 
after replication stress was enhanced in Dicer Ex5/Ex5 
cells (Figure 1D), further supporting a role for Dicer in 
maintaining genomic stability. 
We then investigated whether the frequency of 
chromosome breaks increased at CFSs, by focusing on 
FRA3B, the CFS that shows the highest frequency of 
breakage after replication stress in HCT116 cells [43]. 
To this end, we knocked down Dicer or Drosha by 
siRNA before inducing replication stress using low doses 
aphidicolin. Fluorescence in situ hybridization (FISH) was 
performed on metaphase spreads using a FRA3B specific 
probe. By counting the number of breaks, we found that 
fragility at FRA3B significantly increases in the absence 
of both Dicer and Drosha (12,8% in control cells, 26,7% 
and 19,5% in siDicer and siDrosha cells respectively) 
(Figure 1E and 1F). To confirm our finding, we also 
examined FRA3B fragility in Dicer Ex5/Ex5 cells. In 
line with our previous results, Dicer Ex5/Ex5 cells were 
more susceptible to breakage at FRA3B after inhibition 
of replication by aphidicolin, compared to their WT 
counterparts (Figure 1G; 11% and 22% in WT and Dicer 
Ex5/Ex5 cells respectively). Taken together these data 
indicate that Dicer is required for preventing chromosome 
instability at CFSs.
Inhibition of Dicer impairs FANCD2 
foci assembly without affecting its mono-
ubiquitylation
To study the role of Dicer in the response to 
replication stress, cells were assessed for phosphorylated 
H2A.X at serine 139 (γH2AX) nuclear foci, an 
established marker of DNA damage [47]. Surprisingly, 
immunofluorescence analysis of HCT116 cells after RNAi 
targeting either Dicer or Drosha showed that inhibition 
of the Dicer pathway does not affect γH2AX levels after 
replication stress compared to control cells (Supplementary 
Figure 2A and 2B). γH2AX staining was also unaffected 
in aphidicolin-treated Dicer Ex5/Ex5 cells (Supplementary 
Figure 2C–2E), indicating that the early response to 
replication stress and DNA damage [48] is not affected by 
Dicer deficiency. 
We then investigated the foci formation of FANCD2, 
a protein of the FA pathway that stabilizes replication 
forks undergoing replication stress [49] and maintain 
CFS stability throughout S-phase and mitosis [50–52]. 
As shown in Figure 2A and 2B, the downregulation of 
Dicer significantly inhibits the formation of FANCD2 
foci induced by replication stress. In order to verify these 
results, we repeated the experiment using the Dicer Ex5/
Ex5 cell line and found that FANCD2 foci assembly was 
also compromised (Figure 2C and 2D). 
It has been shown that FANCD2 foci formation 
is dependent on its mono-ubiquitylation by the FA 
complex [53]. We therefore set out to investigate whether 
Dicer pathway is involved in the mono-ubiquitylation 
of FANCD2. Dicer or Drosha were downregulated by 
siRNAs and the cells were treated with aphidicolin 
to induce replication stress. Mono-ubiquitylation of 
FANCD2, assessed as the ratio between the slow and fast 
migrating FANCD2 forms by western blotting, remained 
unaffected by the knock down of both Dicer and Drosha 
(Figure 2E and 2F). The experiment was repeated using 
WT and Dicer Ex5/Ex5 cells, confirming the previous 
result (Figure 2G). 
Altogether, the above results indicate that Dicer is 
not involved in the mono-ubiquitylation of FANCD2, but 
it promotes FANCD2 foci formation downstream of its 
mono-ubiquitylation. 
Dicer is essential for activating the S-phase 
checkpoint after replication stress
To further investigate the mechanisms underlying 
Dicer function in genomic stability after replication 
stress, we analyzed the behavior of TopBP1, another 
protein fundamental for replication stress response 
and CFS maintenance [54, 79]. Similar to FANCD2, 
TopBP1 foci formation was significantly reduced in the 
Dicer-deficient cells (Figure 3A and 3B). Since TopBP1 
recruitment is essential for activating the ATR-dependent 
checkpoint [16], we then compared the efficiency of the 
S-phase checkpoint signaling in WT and Dicer Ex5/Ex5 
cells treated with aphidicolin. Checkpoint activation was 
analyzed by quantifying the levels of phosphorylated 
Chk1 (at serine 345) and ATR (at threonine 1989), 
established marks of the S-phase checkpoint [55–57]. 
Analysis by western blotting showed that the levels of 
both phosphorylated Chk1 and ATR after aphidicolin 
treatment were reduced in absence of a fully functional 
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Figure 1: Inhibition of the Dicer pathway enhances genomic instability after replication stress. (A) Western blot showing 
Dicer and Drosha down-regulation after siRNA treatment in HCT116 cells. Piwi was used as an RNAi off-target control. GAPDH was 
used as a loading control. (B) Representative DAPI-stained metaphase spreads of cells treated with aphidicolin. (C) Inhibition of Dicer 
and Drosha enhances chromosome breakage after aphidicolin treatment. Dicer or Drosha expression were transiently inhibited by siRNA 
and cells were treated with aphidicolin to induce replication stress. Metaphase spreads were then prepared and analyzed by fluorescence 
microscopy. The graph presents the average number of chromosome breaks per metaphase. Error bars represent the SD of three independent 
experiments. Unpaired t-test: *p < 0.05, ***p < 0.001. (D) Dicer-deficient HCT116 cells (Dicer Ex5/Ex5) show enhanced chromosomal 
fragility after aphidicolin treatment. WT and Dicer-deficient cells were treated with aphidicolin to induce chromosome breaks and were then 
processed for preparation of metaphase spreads. Metaphase spreads were stained with DAPI and analyzed by fluorescence microscopy. The 
graph presents the average number of chromosome breaks per metaphase. Error bars represent the SD of three independent experiments. 
Unpaired t-test: *p < 0.05. (E) Quantification of the FISH analysis for FRA3B, after inhibition of Dicer and Drosha by siRNA and induction 
of replication stress by aphidicolin. The graph presents the percentage of broken FRA3B sites. Error bars represent the SD of three 
independent experiments. Unpaired t-test: *p < 0.05. (F) Representative FISH images using a probe for the FRA3B fragile site. The white 
arrow indicates a characteristic chromosomal break. DNA was stained with DAPI and metaphase spreads were analyzed by fluorescence 
microscopy. (G) Graph presenting the results of the FISH analysis in Dicer-deficient and WT HCT116 cells after treatment with DMSO 
(−) or aphidicolin (+). The percentage of fragile FRA3B sites is shown. Error bars represent the SD of three independent experiments. 
Unpaired t-test: ***p < 0.001.
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Figure 2: Dicer inhibition prevents FANCD2 foci formation after replication stress without affecting FANCD2 mono-
ubiquitylation. (A) HCT116 cells were treated with control or Dicer siRNA and then with aphidicolin to induce replicative stress. They 
were then stained for FANCD2 and analyzed by immunofluorescence microscopy. (B) Quantification of the experiments in panel (A) 
showing the percentage of FANCD2 positive cells. Error bars represent the SD of three independent experiments. To score the FANCD2 
positive cells a threshold value was calculated on the base of the average number of foci in control cells for each replicate, using Image 
J. Unpaired t-test: *p < 0.05. (C) FANCD2 foci formation in WT and Dicer Ex5/Ex5 cells after replication stress induced by aphidicolin. 
(D) Quantification of the experiments in panel (C) showing the percentage of FANCD2 positive cells. Error bars represent the SD of 
three independent experiments. Unpaired t-test: **p < 0.005. (E) Western blotting showing the levels of FANCD2 mono-ubiquitylation 
(L-FANCD2) after siRNA-mediated inhibition of Dicer, in the presence or absence of replication stress induced by aphidicolin. Vinculin 
was used as a loading control. (F) Western blotting showing FANCD2 mono-ubiquitylation levels after Drosha inhibition by siRNA. (G) 
FANCD2 mono-ubiquitylation levels in WT and Dicer Ex5/Ex5 cells assayed by western blotting. 
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Dicer pathway, while total levels of Chk1 or ATR were 
not affected (Figure 4A), indicating that the S-phase 
checkpoint activation was significantly inhibited. 
We then set out to confirm the role of Dicer 
in regulating the S-phase checkpoint by performing 
immunofluorescence analysis. In accordance to the 
previous western blotting results, we observed a decrease 
in the focal staining of phosphorylated ATR in absence of 
functional Dicer, in response to replication stress (Figure 
4B and 4C). Moreover, immunofluorescence analyses 
showed a strong inhibition of Chk1 phosphorylation after 
aphidicolin treatment in the absence of functional Dicer 
(Figure 4D and 4E). 
Likewise, the levels of Chk1 phosphorylation on 
serine 345 in response to replication stress determined by 
western blotting (Figure 4F) were reduced after RNAi-
mediated inhibition of the Dicer pathway. The decreased 
Chk1 phosphorylation after replication stress was also 
observed in Dicer-depleted HeLa cells (Supplementary 
Figure 3A).
To further support the role of Dicer in replication 
stress response and its impact on DNA damage, we 
analyzed the levels of RPA2 phosphorylation on serine 
33 (a specific target of ATR). The aphidicolin treatment 
induced a sharp increase of RPA2 phosphorylation 
at 16h in WT cells, indicating the activation of ATR 
checkpoint. On the contrary, RPA2 phosphorylation was 
not induced at the same level in Dicer Ex5/Ex5 cells, 
confirming that the ATR-dependent checkpoint was not 
fully activated (Supplementary Figure 3B). Defective 
checkpoint activation following replication stress leads to 
the accumulation of single-stranded DNA [11]. Therefore, 
we compared the levels of nuclear RPA in WT and 
Dicer deficient cells at different time points following 
aphidicolin treatment. Immunofluorescence analysis 
showed higher amounts of nuclear RPA in Dicer Ex5/Ex5 
cells starting from 8h after treatment. (Figure 4G and 4H). 
These data strongly suggest that the ATR-Chk1 dependent 
checkpoint signaling is dysfunctional in the absence of 
functional Dicer or Drosha. 
Inhibition of Dicer prevents the cell cycle arrest 
induced by replication stress
To confirm the impairment of the S-phase 
checkpoint after inhibition of Dicer, WT and Dicer Ex5/
Ex5 HCT116 cells were treated for 24 h with aphidicolin 
to induce replication stress before being released for 3h in 
normal medium. Cell cycle profiles were then analyzed 
by flow cytometry. BrdU and PI staining showed that 
WT cells treated with aphidicolin arrested in S phase 
with only 2.3% of cells entering G2-M, likely as a 
consequence of fork slowing and checkpoint activation 
to give time to repair any damage induced by replication 
stress. By contrast, a significantly higher percentage of 
Dicer-deficient cells (9.1%) proceeded to G2-M (Figure 
5A and 5B). We also quantified the fraction of cells 
with duplicated genome content (late S and G2-M cells, 
indicated as 4C DNA content in Figure 5A and 5B). 
Aphidicolin treatment led to a strong inhibition of genome 
duplication in WT HCT116 cells, with only 17.4% of cells 
having 4C DNA (Figure 5B). On the other hand, in Dicer 
Ex5/Ex5 cells, aphidicolin treatment did not lead to a firm 
cell cycle arrest, with the vast majority of cells progressing 
through S-phase and G2-M (38.6% of the cells exhibit a 
4C DNA content) (Figure 5B). When WT HCT116 cells 
were released from aphidicolin for 3 hours, they re-entered 
the cell cycle proceeding to late S and starting to enter 
G2-M phase (Figure 5A and 5B). Dicer Ex5/Ex5 cells 
instead proceeded from late S to G2-M and from G2-M to 
the next G1 phase (Figure 5A and 5B). Accordingly, the 
percentage of cells in both late S and G2-M phase (cells 
with 4C DNA content) was comparable between WT 
HCT116 and Dicer Ex5/Ex5 cells (Figure 5B). However, 
Figure 3: TopBP1 nuclear foci formation induced by replication stress is Dicer-dependent. (A) Immunofluorescence and 
microscopy analysis of mock (DMSO) or aphidicolin-treated WT and Dicer Ex5/Ex5 HCT116 cells stained for TopBP1. (B) Quantification 
of the experiments in panel (A) showing the percentage of TopBP1 positive cells. Error bars represent the SD of three independent 
experiments. To score the TopBP1 positive cells a threshold was applied on the base of signal intensity in control cells for each replicate. 
Unpaired t-test: **p < 0.005. 
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Figure 4: Inhibition of Dicer impairs the S-phase checkpoint. (A) WT and Dicer-deficient HCT116 cells were treated with 
DMSO (−) or aphidicolin (+) and then assayed for several markers of the S-phase checkpoint by Western blotting. GAPDH was used as 
loading control. Total ATR and Chk1 levels were assayed and used as controls for the changes in phospho-ATR and phospho-Chk1 levels 
respectively. (B) Phosphorylation of ATR was assayed by immunofluorescence in WT and Dicer Ex5/Ex5 cells treated with DMSO (Mock) 
or aphidicolin (left panel). DNA was stained with DAPI. The cells were analyzed by microscopy. (C) Quantification of the experiments in 
panel (B), showing the percentage of phospho-ATR positive cells. Error bars represent the SD of three independent experiments. A threshold 
was applied on the base of the signal intensity in control cells for each replicate. Unpaired t-test: *p < 0.05. (D) Immunofluorescence 
experiment showing inhibition of aphidicolin-induced Chk1 phosphorylation at serine 345 after aphidicolin treatment in the absence of 
functional Dicer. (E) Quantification of the experiments in panel (D), showing the percentage of phospho-Chk1-positive cells. Error bars 
represent the SD of three independent experiments. A threshold was applied on the base of the signal intensity in control cells for each 
replicate. Unpaired t-test: **p < 0.005. (F) Western blotting showing inhibition of Chk1 phosphorylation in the absence of Dicer or Drosha. 
HCT116 cells were treated with siRNA against Dicer or Drosha and then treated with DMSO (−) or aphidicolin (+) to activate the replication 
checkpoint. (G) Representative immunofluorescence experiment showing the increase of nuclear RPA after aphidicolin treatment in the 
absence of functional Dicer. (H) Quantification of nuclear RPA signal intensity at the indicated time points after aphidicolin addition. Error 
bars represent the SEM of three independent experiments. Mann-Whitney test: ****p < 0.0001.
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Figure 5: Inhibition of Dicer impairs aphidicolin-induced cell cycle arrest in S phase. (A) Representative cell cycle profiles 
of WT and Dicer-deficient HCT116 cells stained with BrdU after 24h aphidicolin treatment and 3 h after removal of aphidicolin (3 
h release). Cells were incubated with anti-BrdU antibodies, stained with propidium iodide (PI) and analyzed by flow cytometry. The 
proportion of cells in the different phases of the cell cycle is indicated. (B) Quantification of the cells in each cell cycle phase and of cells 
with 4C DNA content (late-S and G2-M cells). Error bars represent the SEM of four independent experiments. Unpaired t-test: *p < 0.05, **p 
< 0.005. (C) Dicer-deficient cells escape the S-phase arrest and enter mitosis after aphidicolin treatment. WT and Dicer-deficient HCT116 
cells were treated with aphidicolin, which was then removed (3 h release). Cells were analyzed by immunofluorescence and microscopy, 
after staining for phosphorylated Histone H3 (S10), a known marker of mitosis. (D) Quantification of the experiments in panel (C). Error 
bars represent the SEM of four independent experiments. Unpaired t-test: ns not significant, *p < 0.05. 
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the percentage of G2-M cells tended to be higher in Dicer 
Ex5/Ex5 cells than in WT HCT116 (24.4% vs 14.9%) 
(Figure 5B).    
To examine whether these cells reach mitosis 
after replication stress, we stained the cells for Histone 
H3 phosphorylated at serine 10, a well-known marker 
of mitotic chromatin condensation (Figure 5C and 5D). 
As expected, immunofluorescence analysis showed that 
aphidicolin treatment leads to a strong inhibition of mitotic 
entry in WT cells, as consequence of their functional 
S-phase checkpoint that keeps them from progressing 
through the cell cycle. Conversely, as quantified in 
Figure 5D, a significant fraction of Dicer Ex5/Ex5 cells 
escaped the cell cycle arrest and entered into mitosis. 
Moreover, this analysis showed that 3 hours after release 
from aphidicolin, a higher proportion of Dicer Ex5/Ex5 
cells are in mitosis when compared to WT cells (5.1% vs 
2.9%). Overall, these data show that Dicer is required for 
arresting the cell cycle in S phase after replication stress, 
and to prevent cells from entering mitosis with unrepaired 
DNA damage or under-replicated DNA. 
Dicer deficiency increases mitotic transmission 
of DNA damage in response to replication stress
To further confirm the involvement of Dicer in 
preserving genome stability during replication stress, we 
tested the formation of 53BP1 bodies, nuclear structures 
that assemble around DNA lesions generated from the 
under-replicated DNA persisting in the previous mitosis 
[58]. WT and Dicer Ex5/Ex5 cells were treated with 
aphidicolin and then analyzed by immunofluorescence 
using antibodies directed against 53BP1 and Cyclin A, 
to quantify the G1 cells with 53BP1 bodies. As shown 
in Figure 6A and 6B, the absence of functional Dicer led 
to a significant increase in the number of G1 (Cyclin A 
negative) cells with 53BP1 bodies (50,9%) as compared 
to WT cells (34,7%), confirming that Dicer function is 
required to prevent the formation of replication induced 
DSB and to limit their transmission to daughter cells.
DISCUSSION
In this study, we examined the role for Dicer 
in the DNA damage response induced by replication 
stress. To this end, we focused our work on CFSs, 
which are particularly prone to breakage following 
replication stress. Our data clearly show that inhibition 
of the Dicer pathway, either by siRNA targeting Dicer 
and Drosha or using a Dicer-deficient cellular model, 
prevents the efficient and timely resolution of stalled 
replication forks, leading to enhanced chromosome 
fragility and accumulation of 53BP1 bodies. This effect 
can be attributed to the involvement of Dicer in the 
activation of the replication checkpoint since the S-phase 
checkpoint was weakened in the absence of a functional 
Dicer protein. The deficient checkpoint signaling led 
to a prominent inhibition of cell cycle delay in S-phase 
and uncontrolled progressing of cells with under-
replicated DNA in G2-M phase. Indeed, this S-phase 
arrest is essential to give cells time to resolve the stalled 
replication forks, avoiding their collapse and subsequent 
chromosome breakage during mitosis [59–62]. However, 
whether this role of Dicer is mediated via its miRNA 
synthesis function or via a non-canonical miRNA-
independent function [63, 64] remains to be determined.
FANCD2 is a protein of the FA pathway that has 
an important role in preventing genomic instability in 
conditions of replication stress. Our study shows that the 
Dicer-pathway promotes FANCD2 assembly into nuclear 
foci following replication stress. However, we show 
that FANCD2 is efficiently mono-ubiquitylated in the 
Figure 6: Dicer inhibition causes increase in 53BP1 nuclear bodies. (A) Immunofluorescence and microscopy analysis of mock 
or aphidicolin-treated WT and Dicer Ex5/Ex5 cells stained for 53BP1 and Cyclin A. (B) Quantification of the experiment in panel (A), 
showing the percentage of Cyclin A negative cells with 53BP1 bodies. Error bars represent the SEM of three independent experiments. 
Unpaired t-test: **p < 0.005. 
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absence of Dicer, suggesting that miRNA pathway acts on 
FANCD2 response to replication stress (foci formation) 
through another mechanism. Noteworthy, deficiency 
of USP1 (the FANCD2 deubiquitylating enzyme) leads 
to a constitutively mono-ubiquitylated FANCD2, yet 
impairs its foci formation, showing that FANCD2 mono-
ubiquitylation is necessary but not sufficient to induce 
FANCD2 foci formation [65]. In addition, it has been 
shown that the role of FANCD2 in controlling replisome 
function is independent from its mono-ubiquitylation by 
the FA core [49]. One possibility is that Dicer or small 
RNAs promote FANCD2 mobilization or retention to 
the site of replication fork stalling. Future work will 
be needed to further clarify this important issue. Apart 
from FANCD2, cells lacking functional Dicer treated 
with aphidicolin also fail to induce the accumulation of 
TopBP1 foci, an essential ATR activator. The interaction 
between TopBP1 and the ATR-ATRIP complex at stalled 
replication forks is essential for activating the S-phase 
checkpoint [16]. On the other hand, it has been shown 
that the mono-ubiquitylation of FANCD2 is TopBP1-
independent, which is consistent with the fact that mono-
ubiquitylation of FANCD2 remains unaffected in the 
absence of Dicer [66].
Our study demonstrates a role for Dicer in the DNA 
damage response induced by replication stress in human 
cells. Treatment of cells with mild doses of aphidicolin 
leads to replication stress that, in the presence of functional 
Dicer, activates the S-phase checkpoint. This checkpoint 
has an important function in preventing the unscheduled 
activation of late replication origins, that often co-
localize at CFSs [1, 2, 10, 67, 68]. Moreover, the S-phase 
checkpoint results in cell cycle arrest, giving the cells time 
to resolve stalled forks and prevent further induction of 
DNA damage. On the other hand, in the absence of Dicer, 
the S-phase checkpoint is not fully functional. This could 
allow unrestrained origin activation and DNA synthesis at 
late replicating regions, including CFSs, and at the same 
time preventing cell cycle arrest. Consequently, cells 
proceed into mitosis with under-replicated DNA resulting 
in chromosome breakage and DNA damage accumulation 
in daughter cells (Figure 7).
Our data show that Dicer has a function in the 
activation of the ATR pathway, as Dicer deficient cells 
fail to phosphorylate ATR and its main effectors RPA2 
and Chk1, without affecting H2A.X phosphorylation. 
This suggests that Dicer acts upstream of the ATR-
Chk1 pathway preventing unscheduled origin firing 
and limiting ssDNA accumulation (Figure 4), which 
can lead to replication catastrophe upon stringent 
replication stress [69]. Noticeably, this may explain why 
a partial suppression of Dicer function promotes tumor 
development yet its complete loss is not tolerated in 
cancer cells that have to sustain high levels of replication 
stress [70]. The specific mechanism by which Dicer 
functions to control the S-phase checkpoint and prevent 
chromosome breakage remains unknown. Nevertheless, 
it has been shown that, in the case of double-strand 
breaks, small Dicer-dependent RNAs act by recruiting 
chromatin modifiers, which add chromatin marks that 
are used as guides to attract repair factors at the sites 
of breaks [29, 31]. In fission yeast, Dicer was shown to 
act by unloading RNA Pol II from chromatin, to avoid 
transcription-replication collisions [40] that otherwise 
would lead to chromosomal damage [71]. Another 
study has that in response to DNA damage induced by 
UVs, miRNAs can target CDC25A, one of the main 
effectors of the ATR-Chk1 pathway involved in the 
intra-S phase arrest [72]. It is also widely accepted that 
replication stalling can lead to the functional uncoupling 
of helicase and polymerase complexes. In this context, 
the unwinding of the double stranded DNA produces 
long stretches of single-stranded DNA (ssDNA) [73]. 
These stretches of ssDNA could represent docking sites 
for RNA-mediated epigenetic modifications that are 
necessary in the response to replication stalling. Dicer 
products transcribed from genomic regions mapping 
to CFSs could bind specifically to those chromosomal 
regions by base complementarity and function as guides 
for chromatin modifiers. miRNAs could also bind 
to single-stranded DNA to prevent the formation of 
complex secondary structures that are prone to breakage. 
Alternatively, Dicer may also have an RNA-independent 
function in regulating the S-phase checkpoint by 
controlling the binding of DNA repair proteins at stalled 
replication forks. Since CFS are particularly prone to 
undergo replication-transcription collisions and R-loop 
formation [4], Dicer and Drosha may be involved in 
dynamic processing of these structures [41], allowing on 
one side a proper checkpoint activation and, on the other, 
stable chromatin association of proteins, like FANCD2, 
that stabilize the forks and promote R-loop resolution 
[49, 51, 74–76]. These possibilities remain to be 
investigated, in order to identify the exact mechanism by 
which Dicer maintains genome stability upon replication 
stress.
MATERIALS AND METHODS
Cell lines and treatments
All experiments were performed using the colorectal 
cancer cell line HCT116, except for the experiments in 
Supplementary Figure 3A performed in HeLa cells 
(ATCC). Dicer Ex5/Ex5 cells and their WT counterparts 
were kind gifts from Dr Bert Vogelstein [45]. Cells were 
grown in McCoy’s 5A medium (Life Technologies), 
supplemented with 10% FBS (Eurobio) and antibiotics 
(Life Technologies). Replication stress was induced by 
treating cells with aphidicolin at a concentration of 0.7 




Cells were transfected with siRNA pools targeting 
Dicer (Dharmacon, #M-003483-00-0005) or Drosha 
(Dharmacon, #M-016996-02-0005) using Interferin 
(Polyplus), following the manufacturer’s instructions. For 
mock treated cells, a non-targeting pool of siRNAs was 
used (Dharmacon, #D-001206-13-05). Cells were treated 
with siRNA pools for 60 h (Dicer) and 84 h (Drosha), 
and were then either collected for analysis or treated with 
aphidicolin (as described above), to induce replication 
stress.
Western blotting
Cells were collected, washed with PBS, and 
resuspended in 2.5 volumes of lysis buffer (50 mM Tris.
HCl pH 7.5, 20 mM NaCl, 1 mM MgCl2, 0.1% SDS) 
supplemented with a cocktail of protease and phosphatase 
inhibitors (Life Technologies or Roche) and benzonase 
(0.025 units/μl, Novagen). Samples were incubated on a 
shaking platform at room temperature for 15 min and then 
centrifuged at 16,000 g for 20 min at 4° C. The protein 
supernatants were collected and protein concentrations 
were measured using the BCA protein assay kit (Pierce) 
or the Bradford assay (Biorad). 10–40 µg of total protein 
extracts from each sample were resolved on 7%, 3–8% and 
4–12% gradient sodium dodecyl sulfate-polyacrylamide 
gels (Life Technologies or Biorad). Protein samples were 
then transferred onto nitrocellulose or PVDF membranes 
(Life Technologies or Biorad), which were then blocked 
for 3–5 h in blocking solution (5% milk powder –0.1% 
Tween in PBS) at room temperature. The membranes 
were incubated with primary antibodies overnight at 4 °C, 
Figure 7: Model. Dicer inhibition causes a defective S-phase checkpoint activation in response to DNA replication stress, allowing cells 
to enter mitosis despite the presence of incompletely replicated DNA. As a result, cells undergo chromosomal breakage and eventually 
formation of 53BP1 nuclear bodies in the next G1.
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washed three times with PBS-0.1% Tween, incubated with 
secondary antibodies for 1 h at room temperature, and 
finally washed three times with PBS-0.1% Tween. Blots 
were visualized using either an ECL assay (Ozyme or 
Advansta) or an immunofluorescence detection protocol, 
following the manufacturer’s instructions. 
The primary antibodies used were the following: 
anti-Dicer (Abcam, #ab14601), anti-Drosha (Abcam, 
#ab12286), anti-Piwi (Abcam, #ab12337), anti-GADPH 
(Abcam, #ab8245), anti-chk1 (Cell signaling, #2360), 
anti-phospho-chk1 (serine 345) (Cell Signaling, #2348), 
anti-ATR (Cell signaling, #2790), anti-phospho-ATR 
(threonine 1989) (Genetex, #GTX128145), anti-FANCD2 
(Santa Cruz, #sc-20012), anti-FANCD2 (Novus, #NB-
100-182), anti-TopBP1 (Abcam, #ab2402), anti-Vinculin 
(Abcam, #ab180581), anti-Lamin A/C (Santa Cruz, #sc-
7292), anti-RPA2 (Calbiochem, #NA18), anti-phospho-
RPA2 (serine33) (Bethyl, #A300-246A, a kind gift of 
Dr. Stéphane Koundrioukoff) and anti-GFP (Roche, 
#11814.460001). Horseradish peroxidase-conjugated 
antibodies (Jackson Immunoresearch, #85100 and 
#81283; Bethyl, #A90-1375 and #A120-1088) were 
used as secondary antibodies for ECL detections. Alexa 
Fluor 750- conjugated Goat anti-mouse (#A21037) and 
Goat-anti-Rabbit (#A21039) (Thermofisher Scientific) 
were used as fluorescent secondary antibodies and the 
corresponding acquisitions were then performed using 
GBOX (Ozyme).
Metaphase spreads
After aphidicolin treatment, cells were washed 
with medium and left in the incubator in the presence of 
10 µM nocodazole for 6 h. Cells were then trypsinized, 
transferred into tubes and centrifuged. Each cell 
pellet was then resuspended in 10 ml of warm (37° C) 
hypotonic buffer (10 mM KCl, 15% FBS) for 10 min 
at 37° C. Cold (4° C) fixation buffer (25% acetic acid, 
75% ethanol) was then added (0.5 ml per sample) at 
37° C and cells were then immediately centrifuged. 
Cell pellets were washed 5 times with 6 ml of cold 
fixation buffer and were finally kept in a small volume 
(100–200 μl) of cold fixation buffer. The samples were 
then used to prepare metaphase spreads by transferring 
a single drop of fixed cells with a Pasteur pipette onto 
a wet microscope slide. For each experiment, at least 
80 metaphases per condition were analyzed by visual 
inspection of microscopy images using the Image J, in a 
non-blinded manner.
Probe preparation
200 μl of BAC DNA (clone RP11-147N7, located 
in FRA3B) were sonicated using the Bioruptor UCD-300 
(20–25 one-min cycles), at a concentration of 25 ng/μl. 
The sonicated DNA was then subject to labelling by 
using the Platinum Bright kit by Kreatech, following the 
manufacturer’s instructions.
50 ng of labelled probe were mixed with 50 µg of 
herring sperm DNA (Life Technologies) and 10 µg of 
COT human DNA (Kreatech), in a total volume of 50 µl. 
DNA was then precipitated by adding 10 % sodium acetate 
and 2.5 volumes of pure ice-cold ethanol and incubating 
the sample at –80° C for 1–2 h. The samples were then 
centrifuged (13,000 rpm, 15 min, 4° C) and pellets 
were washed with 70% ethanol (300 μl). Samples were 
centrifuged again and pellets were then left to dry. They 
were suspended in 10 μl of hybridization solution (40 % 
formamide, 10% dextran sulfate, 2× SSC), denatured at 
95°C for 5 min and kept on ice.
Fluorescence in situ hybridization (FISH)
The hybridization reaction has been previously 
described [77]. In brief, the slides with metaphase spreads 
were incubated at 80° C for 1 min, in the presence of 
denaturing solution (70% formamide, 2x SSC). The slides 
were then successively washed in 70%, 90% and 100% 
ethanol for 3 min and were left to dry. The denatured 
probe was then added on top of the slides, with the help 
of a coverslip, and the slides were incubated in a humid 
chamber at 37° C overnight. The slides were then washed 
in washing buffer (0.5× SSC, 0.1% SDS) for 5 min at 
65° C, then with PBS for 5 min at room temperature and 
were finally analyzed by fluorescence microscopy, after 
adding a drop of Vectashield mounting medium (Vector 
laboratories, # H-1200) per slide.
Immunofluorescence and microscopy
Cells were grown on coverslips and then washed 
twice with PBS before fixation with formaldehyde (4%) 
for 10-15 min at room temperature. For phospho-Histone3 
serine 10 antibody (Cell Signaling, #9701), the following 
protocol was performed. Cells were washed with PBS 
and incubated in blocking buffer (0.5% Igepal, 5% milk 
powder, 1% FBS) for 30 min at room temperature. After 
being washed with PBS, cells were incubated overnight at 
4° C with primary antibodies, in a buffer containing 5% 
milk powder and 1% FBS. Coverslips were washed with 
PBS and then incubated in the same buffer, containing 
secondary antibodies (goat anti-rabbit FITC, #4050-02 
from Southern Biolabs and Alexa Fluor 568 goat anti-
rabbit, #A11011 from Life Technologies), for 45-60 
min at room temperature. Cells were washed twice with 
PBS, once with distilled water and were then transferred 
on microscope slides containing 20 μl of Vectashield 
mounting medium. 
For phospho-Chk1 serine 345 (Cell Signaling, 
#2348), TOPBP1 (Santa Cruz, sc-32923), 53BP1 (Abcam, 
#ab36823), FANCD2 (Abcam, #ab2187), phospho-H2AX 
(serine 139) (Cell Signaling, #2577), Cyclin A2 (Abcam, 
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#ab38) and RPA2 (Calbiochem, #NA18) antibodies, cells 
were fixed as above and then permeabilized using PBS-
0.5% Triton X-100 for 15 min, before being blocked with 
blocking solution (PBS-3% BSA-0.05% Tween) for 1-3 
h at room temperature. Coverslips were then incubated 
with the primary antibodies (diluted in blocking solution) 
overnight at 4° C. Coverslips were then washed 3 times 
with PBS and incubated with the corresponding secondary 
antibodies (goat anti-rabbit FITC, #4050-02 from Southern 
Biolabs; Alexa Fluor 568 goat anti-rabbit #A11011, Alexa 
Fluor 488 goat anti-rabbit #A21206 and Alexa Fluor 
594 goat anti-rabbit #A21207 from Life Technologies) 
diluted in blocking solution, for 45–60 minutes at room 
temperature. After being washed three times (10 min each) 
in PBS and once with distilled water, cells were mounted 
on microscope slides containing Vectashield mounting 
medium or 10 μl of DAPI fluoromount medium from 
Southern Biotech (#0100-20).
For phospho-ATR (threonine 1989) antibody, cells 
were fixed with 100% methanol for 5 min at −20° C, 
permeabilized using 0.1% Tween-20 and washed using 
PBS-0.1% tween-20. All slides were analyzed using a 
Zeiss epifluorescence microscope.
For each experiment, at least 100 cells per condition 
were scored by visual inspection of microscopy images 
using the Image J, in a non-blinded manner. 
Flow cytometry
Cells were treated with 10 µM of BrdU (Sigma) for 
30 min before harvesting. Cells were trypsinized, washed 
with PBS, and centrifuged 10 min at 800 rpm. Cells were 
then fixed in ice-cold 70% ethanol and incubated at 4°C 
overnight, as described [43, 78]. Cell were centrifuged 10 
min at 1000 rpm and the pellet resuspended in denaturing 
solution (0.1M HCl) on ice for 10 min. Cells were then 
diluted in cold distilled water and centrifuged 10 min 
at 1000 rpm. Cell pellets were resuspended in water, 
boiled for 10 min and incubated on ice for 15 min. Cells 
were permeabilized with 0.5% Triton X-100 in PBS, 
centrifuged and incubated with BrdU antibodies (DAKO, 
#M0744) in blocking solution (0.1% BSA in PBS) for 
1 h at room temperature. Cells were washed with cold 
PBS and incubated with secondary antibodies (goat anti-
mouse FITC-conjugated antibodies from Thermo Fisher 
Scientific, #626511) for 45 min at room temperature in 
the dark. Finally, cells were resuspended in PI/RNase 
staining buffer (BD Bioscience, # 550825) and analyzed 
by flow cytometry (BD Accuri C6). The discrimination 
of cell doublets from singlets was made by plotting the 
DNA dye (PI) channel Width versus Area in a dot plot 
graph. The gating was done by separating BrdU positive 
cells (active S-phase) from the negative ones, and by 
distinguishing 2n and 4n content cells (G1 and G2/M 
phase respectively) on the base of DNA content (PI 
staining).
Statistical analysis
Statistical analysis of the FISH data was 
performed using ANOVA and Student’s t-test (two-
tailed). For all other experiments, statistical significance 
was calculated by using the test indicated in the legend. 
Statistical significance is indicated with ns (not 
significant), *(p < 0.05), **(p < 0.005), ***(p < 0.001) or 
****(p < 0.0001).
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